Get startedLog in
    Picture of ImmuneOnco Biopharmaceuticals (Shanghai) logo

    1541 — ImmuneOnco Biopharmaceuticals (Shanghai) News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapSucker Stock
    All News

    Brief: Immuneonco Biopharmaceuticals Announces Registrational Strategy In Collaboration With Instil

    Picture of ImmuneOnco Biopharmaceuticals (Shanghai) logoImmuneOnco Biopharmaceuticals (Shanghai)
    16/09/2024 17:48
    Sept 16 (Reuters) - ImmuneOnco Biopharmaceuticals
Shanghai Inc  1541.HK :
    * GLOBAL REGISTRATIONAL STRATEGY IN COLLABORATION WITH
INSTIL FOR
PD- L1XVEGF BISPECIFIC ANTIBODY
    * ACCELERATING DEVELOPMENT OF PD- L1XVEGF BISPECIFIC
ANTIBODY DRUG

Further company coverage:  1541.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on ImmuneOnco Biopharmaceuticals (Shanghai)

    See all news